Obesity hypoventilation syndrome: A state-of-the-art review

Respiratory Care

Volumn 55, Issue 10, 2010, Pages 1347-1362

  Mokhlesi, Babak ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Bi level PAP; CPAP; Hypercapnia; Hypoventilation; Obesity hypoventilation syndrome; Pickwickian syndrome; Sleep apnea; Sleep disordered breathing

Indexed keywords

ACETAZOLAMIDE; BICARBONATE; LEPTIN; MEDROXYPROGESTERONE;

APNEA HYPOPNEA INDEX; ARTICLE; BARIATRIC SURGERY; BICARBONATE BLOOD LEVEL; BREATHING MECHANICS; BREATHING MUSCLE; CLINICAL FEATURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; HUMAN; HYPERCAPNIA; LUNG VOLUME; MORBIDITY; OBESITY HYPOVENTILATION SYNDROME; OXYGEN SATURATION; OXYGEN THERAPY; PATHOPHYSIOLOGY; PHLEBOTOMY; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; PRESSURE SUPPORT VENTILATION; PREVALENCE; QUALITY OF LIFE; RESPIRATORY DRIVE; RISK FACTOR; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; TRACHEOSTOMY; UPPER RESPIRATORY TRACT OBSTRUCTION; WEIGHT REDUCTION;

ACIDOSIS, RESPIRATORY; BLOOD GAS ANALYSIS; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; HYPERCAPNIA; OBESITY HYPOVENTILATION SYNDROME;

EID: 78149397001     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (125)

1. Lugaresi E, Coccagna G, Tassinari CA, Ambrosetto C. [Particularités cliniques et polygraphiques du syndrome d'impatience des membres inférieurs]. Rev Neurol 1965;115:545. Article in French.
2. Gastaut H, Tassinari CA, Duron B. Polygraphic study of the episodic diurnal and nocturnal (hypnic and respiratory) manifestations of the Pickwick syndrome. Brain Res 1966;1(2):167-186.
3. Lavie P. Who was the first to use the term Pickwickian in connection with sleepy patients? History of sleep apnoea syndrome. Sleep Med Rev 2008;12(1):5-17.
4. Sotos JG. Taft and Pickwick: sleep apnea in the White House. Chest 2003;124(3):1133-1142.
5. Auchincloss JH Jr, Cook E, Renzetti AD. Clinical and physiological aspects of a case of obesity, polycythemia and alveolar hypoventilation. J Clin Invest 1955;34(10):1537-1545.
6. Burwell CS, Robin ED, Whaley RD, Bickelmann AG. Extreme obesity associated with alveolar hypoventilation: a Pickwickian syndrome. Am J Med 1956;21(5):811-818.
7. Dickens, C. The posthumous papers of the Pickwick club. Boston: Ticknor and Fields; 1867.
8. Mokhlesi B, Kryger MH, Grunstein RR. Assessment and management of patients with obesity hypoventilation syndrome. Proc Am Thorac Soc 2008;5(2):218-225.
9. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Public Health 2007;121(7):492-496.
10. Prentice A, Webb F. Obesity amidst poverty. Int J Epidemiol 2006;35(1):24-30.
11. Skidmore PM, Yarnell JW. The obesity epidemic: prospects for prevention. QJM 2004;97(12):817-825.
12. Spritzer DA. Obesity epidemic migrates east. CMAJ 2004;171(10):1159.
13. Miech RA, Kumanyika SK, Stettler N, Link BG, Phelan JC, Chang VW. Trends in the association of poverty with overweight among US adolescents, 1971-2004. JAMA 2006;295(20):2385-2393.
14. Verin E, Tardif C, Pasquis P. Prevalence of daytime hypercapnia or hypoxia in patients with OSAS and normal lung function. Respir Med 2001;95(8):693-696.
15. Laaban JP, Chailleux E. Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest 2005;127(3):710-715.
16. Kessler R, Chaouat A, Schinkewitch P, Faller M, Casel S, Krieger J, et al. The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest 2001;120(2):369-376.
17. Resta O, Foschino Barbaro MP, Bonfitto P, Talamo S, Mastrosimone V, Stefano A, et al. Hypercapnia in obstructive sleep apnoea syndrome. Neth J Med 2000;56(6):215-222.
18. Golpe R, Jimenez A, Carpizo R. Diurnal hypercapnia in patients with obstructive sleep apnea syndrome. Chest 2002;122(3):1100-1101.
19. Akashiba T, Akahoshi T, Kawahara S, Uematsu A, Katsura K, Sakurai S, et al. Clinical characteristics of obesity-hypoventilation syndrome in Japan: a multi-center study. Intern Med 2006;45(20):1121-1125.
20. Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans AT. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 2007;11(2):117-124.
21. Kaw R, Hernandez AV, Walker E, Aboussouan L, Mokhlesi B. Determinants of hypercapnia in obese patients with obstructive sleep apnea: a systematic review and meta-analysis of cohort studies. Chest 2009;136(3):787-796.
22. Nowbar S, Burkart KM, Gonzales R, Fedorowicz A, Gozansky WS, Gaudio JC, et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med 2004;116(1):1-7.
23. Masa JF, Celli BR, Riesco JA, Hernandez M, Sanchez De Cos J, Disdier C. The obesity hypoventilation syndrome can be treated with noninvasive mechanical ventilation. Chest 2001;119(4):1102-1107.
24. Mokhlesi B, Tulaimat A, Evans AT, Wang Y, Itani A, Hassaballa HA, et al. Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnea. J Clin Sleep Med 2006;2(1):57-62.
25. Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002;288(14):1758-1761.
26. McTigue K, Larson JC, Valoski A, Burke G, Kotchen J, Lewis CE, et al. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 2006;296(1):79-86.
27. Sakakibara H, Tong M, Matsushita K, Hirata M, Konishi Y, Suetsugu S. Cephalometric abnormalities in non-obese and obese patients with obstructive sleep apnoea. Eur Respir J 1999;13(2):403-410.
28. Yu X, Fujimoto K, Urushibata K, Matsuzawa Y, Kubo K. Cephalometric analysis in obese and nonobese patients with obstructive sleep apnea syndrome. Chest 2003;124(1):212-218.
29. Lee W, Nagubadi S, Kryger MH, Mokhlesi B. Epidemiology of obstructive sleep apnea: a population-based perspective. Expert Rev Respir Med 2008;2(3):349-364.
30. Littleton SW, Mokhlesi B. The Pickwickian syndrome: obesity hypoventilation syndrome. Clin Chest Med 2009;30(3):467-478.
31. Lee WY, Mokhlesi B. Diagnosis and management of obesity hypoventilation syndrome in the ICU. Crit Care Clin 2008;24(3):533-549.
32. Quint JK, Ward L, Davison AG. Previously undiagnosed obesity hypoventilation syndrome. Thorax 2007;62(5):462-463.
33. Berger KI, Ayappa I, Chatr-Amontri B, Marfatia A, Sorkin IB, Rapoport DM, et al. Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep. Chest 2001;120(4):1231-1238.
34. Leech JA, Onal E, Baer P, Lopata M. Determinants of hypercapnia in occlusive sleep apnea syndrome. Chest 1987;92(5):807-813.
35. Perez de Llano LA, Golpe R, Ortiz Piquer M, Veres Racamonde A, Vazquez Caruncho M, Caballero Muinelos O, et al. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest 2005;128(2):587-594.
36. Berg G, Delaive K, Manfreda J, Walld R, Kryger MH. The use of health-care resources in obesity-hypoventilation syndrome. Chest 2001;120(2):377-383.
37. Budweiser S, Riedl SG, Jorres RA, Heinemann F, Pfeifer M. Mortality and prognostic factors in patients with obesity-hypoventilation syndrome undergoing noninvasive ventilation. J Intern Med 2007;261(4):375-383.
38. Resta O, Foschino-Barbaro MP, Bonfitto P, Talamo S, Legari G, De Pergola G, et al. Prevalence and mechanisms of diurnal hypercapnia in a sample of morbidly obese subjects with obstructive sleep apnoea. Respir Med 2000;94(3):240-246.
39. Rapoport DM, Garay SM, Epstein H, Goldring RM. Hypercapnia in the obstructive sleep apnea syndrome: a reevaluation of the Pickwickian syndrome. Chest 1986;89(5):627-635.
40. Olson AL, Zwillich C. The obesity hypoventilation syndrome. Am J Med 2005;118(9):948-956.
41. Banerjee D, Yee BJ, Piper AJ, Zwillich CW, Grunstein RR. Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure. Chest 2007;131(6):1678-1684.
42. Koenig SM. Pulmonary complications of obesity. Am J Med Sci 2001;321(4):249-279.
43. Janssens JP, Derivaz S, Breitenstein E, De Muralt B, Fitting JW, Chevrolet JC, et al. Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the Geneva Lake area. Chest 2003;123(1):67-79.
44. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005;293(15):1861-1867.
45. Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin Sleep Cohort. Sleep 2008;31(8):1071-1078.
46. Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O'Connor GT, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009;6(8):e1000132.
47. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365(9464):1046-1053.
48. Hida W. Quality of life in obesity hypoventilation syndrome. Sleep Breath 2003;7(1):1-2.
49. Budweiser S, Hitzl AP, Jöres RA, Schmidbauer K, Heinemann F, Pfeifer M. Health-related quality of life and long-term prognosis in chronic hypercapnic respiratory failure: a prospective survival analysis. Respir Res 2007;8:92.
50. Atwood CW Jr, McCrory D, Garcia JG, Abman SH, Ahearn GS. Pulmonary artery hypertension and sleep-disordered breathing: ACC Pevidence-based clinical practice guidelines. Chest 2004;126(1 Suppl):72S-77S.
51. Kessler R, Chaouat A, Weitzenblum E, Oswald M, Ehrhart M, Apprill M, et al. Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. Eur Respir J 1996;9(4):787-794.
52. Sugerman HJ, Baron PL, Fairman RP, Evans CR, Vetrovec GW. Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss. Ann Surg 1988;207(5):604-613.
53. Lin CC, Wu KM, Chou CS, Liaw SF. Oral airway resistance during wakefulness in eucapnic and hypercapnic sleep apnea syndrome. Respir Physiol Neurobiol 2004;139(2):215-224.
54. Kaltman AJ, Goldring RM. Role of circulatory congestion in the cardiorespiratory failure of obesity. Am J Med 1976;60(5):645-653.
55. Piper AJ, Grunstein RR. Big breathing: the complex interaction of obesity, hypoventilation, weight loss and respiratory function. J Appl Physiol 2010;101(1):199-205.
56. Norman RG, Goldring RM, Clain JM, Oppenheimer BW, Charney AN, Rapoport DM, et al. Transition from acute to chronic hypercapnia in patients with periodic breathing: predictions from a computer model. J Appl Physiol 2006;100(5):1733-1741.
57. Sharp JT, Henry JP, Sweany SK, Meadows WR, Pietras RJ. The total work of breathing in normal and obese men. J Clin Invest 1964;43:728-739.
58. Rubinstein I, Zamel N, DuBarry L, Hoffstein V. Airflow limitation in morbidly obese nonsmoking men. Ann Intern Med 1990;112(11):828-832.
59. Javaheri S, Colangelo G, Lacey W, Gartside PS. Chronic hypercapnia in obstructive sleep apnea-hypopnea syndrome. Sleep 1994;17(5):416-423.
60. Lopata M, Freilich RA, Onal E, Pearle J, Lourenco RV. Ventilatory control and the obesity hypoventilation syndrome. Am Rev Respir Dis 1979;119(2 Pt 2):165-168.
61. Kress JP, Pohlman AS, Alverdy J, Hall JB. The impact of morbid obesity on oxygen cost of breathing (VO2RESP) at rest. Am J Respir Crit Care Med 1999;160(3):883-886.
62. Kelly TM, Jensen RL, Elliott CG, Crapo RO. Maximum respiratory pressures in morbidly obese subjects. Respiration 1988;54(2):73-77.
63. Sampson MG, Grassino K. Neuromechanical properties in obese patients during carbon dioxide rebreathing. Am J Med 1983;75(1):81-90.
64. Becker HF, Piper AJ, Flynn WE, McNamara SG, Grunstein RR, Peter JH, et al. Breathing during sleep in patients with nocturnal desaturation. Am J Respir Crit Care Med 1999;159(1):112-118.
65. Han F, Chen E, Wei H, He Q, Ding D, Strohl KP. Treatment effects on carbon dioxide retention in patients with obstructive sleep apnea-hypopnea syndrome. Chest 2001;119(6):1814-1819.
66. American Thoracic Society, European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 2002;166(4):518-624.
67. Laffey J, Kavanagh B. Permissive hypercapnia. In: Tobin MJ, editor. Principles and practice of mechanical ventilation. New York: McGraw-Hill Professional; 2006:379.
68. Leech J, Onal E, Aronson R, Lopata M. Voluntary hyperventilation in obesity hypoventilation. Chest 1991;100(5):1334-1338.
69. Berthon-Jones M, Sullivan CE. Time course of change in ventilatory response to CO2 with long-term CPAP therapy for obstructive sleep apnea. Am Rev Respir Dis 1987;135(1):144-147.
70. Lin CC. Effect of nasal CPAP on ventilatory drive in normocapnic and hypercapnic patients with obstructive sleep apnoea syndrome. Eur Respir J 1994;7(11):2005-2010.
71. Zwillich CW, Sutton FD, Pierson DJ, Greagh EM, Weil JV. Decreased hypoxic ventilatory drive in the obesity-hypoventilation syndrome. Am J Med 1975;59(3):343-348.
72. Emirgil C, Sobol BJ. The effects of weight reduction on pulmonary function and the sensitivity of the respiratory center in obesity. Am Rev Respir Dis 1973;108(4):831-842.
73. Jokic R, Zintel T, Sridhar G, Gallagher CG, Fitzpatrick MF. Ventilatory responses to hypercapnia and hypoxia in relatives of patients with the obesity hypoventilation syndrome. Thorax 2000;55(11):940-945.
74. Chouri-Pontarollo N, Borel JC, Tamisier R, Wuyam B, Levy P, Pepin JL. Impaired objective daytime vigilance in obesityhypoventilation syndrome: impact of noninvasive ventilation. Chest 2007;131(1):148-155.
75. Kalra SP. Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions. Peptides 2008;29(1):127-138.
76. Tankersley C, Kleeberger S, Russ B, Schwartz A, Smith P. Modified control of breathing in genetically obese (ob/ob) mice. J Appl Physiol 1996;81(2):716-723.
77. Tankersley CG, O'Donnell C, Daood MJ, Watchko JF, Mitzner W, Schwartz A, et al. Leptin attenuates respiratory complications associated with the obese phenotype. J Appl Physiol 1998;85(6):2261-2269.
78. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334(5):292-295.
79. Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000;118(3): 580-586.
80. Barcelo A, Barbe F, Llompart E, de la Pena M, Duran-Cantolla J, Ladaria A, et al. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. Am J Respir Crit Care Med 2005;171(2):183-187.
81. Shimura R, Tatsumi K, Nakamura A, Kasahara Y, Tanabe N, Takiguchi Y, et al. Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea-hypopnea syndrome. Chest 2005;127(2):543-549.
82. Makinodan K, Yoshikawa M, Fukuoka A, Tamaki S, Koyama N, Yamauchi M, et al. Effect of serum leptin levels on hypercapnic ventilatory response in obstructive sleep apnea. Respiration 2008;75(3):257-264.
83. Phipps PR, Starritt E, Caterson I, Grunstein RR. Association of serum leptin with hypoventilation in human obesity. Thorax 2002;57(1):75-76.
84. Yee BJ, Cheung J, Phipps P, Banerjee D, Piper AJ, Grunstein RR. Treatment of obesity hypoventilation syndrome and serum leptin. Respiration 2006;73(2):209-212.
85. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996;348(9021):159-161.
86. Rapoport DM, Sorkin B, Garay SM, Goldring RM. Reversal of the Pickwickian syndrome by long-term use of nocturnal nasal-airway pressure. N Engl J Med 1982;307(15):931-933.
87. Leech JA, Onal E, Lopata M. Nasal CPAP continues to improve sleep-disordered breathing and daytime oxygenation over long-term follow-up of occlusive sleep apnea syndrome. Chest 1992;102(6):1651-1655.
88. Ayappa I, Berger KI, Norman RG, Oppenheimer BW, Rapoport DM, Goldring RM. Hypercapnia and ventilatory periodicity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2002;166(8):1112-1115.
89. Berger KI, Ayappa I, Sorkin IB, Norman RG, Rapoport DM, Goldring RM. CO2 homeostasis during periodic breathing in obstructive sleep apnea. J Appl Physiol 2000;88(1):257-264.
90. Kawata N, Tatsumi K, Terada J, Tada Y, Tanabe N, Takiguchi Y, et al. Daytime hypercapnia in obstructive sleep apnea syndrome. Chest 2007;132(6):1832-1838.
91. Schafer H, Ewig S, Hasper E, Luderitz B. Failure of CPAP therapy in obstructive sleep apnoea syndrome: predictive factors and treatment with bilevel-positive airway pressure. Respir Med 1998;92(2):208-215.
92. Mokhlesi B. Positive airway pressure titration in obesity hypoventilation syndrome: continuous positive airway pressure or bilevel positive airway pressure. Chest 2007;131(6):1624-1626.
93. Piper AJ, Wang D, Yee BJ, Barnes DJ, Grunstein RR. Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax 2008;63(5):395-401.
94. Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, et al. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med 2008;4(2):157-171.
95. Redolfi S, Corda L, La Piana G, Spandrio S, Prometti P, Tantucci C. Long-term non-invasive ventilation increases hemosensitivity and leptin in obesity-hypoventilation syndrome. Respir Med 2007;101(6):1191-1195.
96. de Lucas-Ramos P, de Miguel-Diez J, Santacruz-Siminiani A, Gonzalez-Moro JM, Buendia-Garcia MJ, Izquierdo-Alonso JL. Benefits at 1 year of nocturnal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Respir Med 2004;98(10):961-967.
97. Piper AJ, Sullivan CE. Effects of short-term NIPPV in the treatment of patients with severe obstructive sleep apnea and hypercapnia. Chest 1994;105(2):434-440.
98. Heinemann F, Budweiser S, Dobroschke J, Pfeifer M. Non-invasive positive pressure ventilation improves lung volumes in the obesity hypoventilation syndrome. Respir Med 2007;101(6):1229-1235.
99. Ambrogio C, Lowman X, Kuo M, Malo J, Prasad AR, Parthasarathy S. Sleep and non-invasive ventilation in patients with chronic respiratory insufficiency. Intensive Care Med 2009;35(2):306-313.
100. Storre JH, Seuthe B, Fiechter R, Milioglou S, Dreher M, Sorichter S, et al. Average volume-assured pressure support in obesity hypoventilation: a randomized crossover trial. Chest 2006;130(3):815-821.
101. Thorne SA. Management of polycythaemia in adults with cyanotic congenital heart disease. Heart 1998;79(4):315-316.
102. Reeves-Hoche MK, Meck R, Zwillich CW. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med 1994;149(1):149-154.
103. Rauscher H, Formanek D, Popp W, Zwick H. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest 1993;103(6):1675-1680.
104. Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147(4):887-895.
105. Haines KL, Nelson LG, Gonzalez R, Torrella T, Martin T, Kandil A, et al. Objective evidence that bariatric surgery improves obesityrelated obstructive sleep apnea. Surgery 2007;141(3):354-358.
106. Pillar G, Peled R, Lavie P. Recurrence of sleep apnea without concomitant weight increase 7.5 years after weight reduction surgery. Chest 1994;106(6):1702-1704.
107. Greenburg DL, Lettieri CJ, Eliasson AH. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med 2009;122(6):535-542.
108. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351(26):2683-2693.
109. Sugerman HJ, Fairman RP, Sood RK, Engle K, Wolfe L, Kellum JM. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr 1992;55(2 Suppl):597S-601S.
110. Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009;361(5):445-454.
111. Fernandez AZ, Jr., Demaria EJ, Tichansky DS, Kellum JM, Wolfe LG, Meador J, et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg 2004;239(5):698-702.
112. Squadrone V, Coha M, Cerutti E, Schellino MM, Biolino P, Occella P, et al. Continuous positive airway pressure for treatment of postoperative hypoxemia: a randomized controlled trial. JAMA 2005;293(5):589-595.
113. Ebeo CT, Benotti PN, Byrd RP, Jr., Elmaghraby Z, Lui J. The effect of bi-level positive airway pressure on postoperative pulmonary function following gastric surgery for obesity. Respir Med 2002;96(9):672-676.
114. El-Solh AA, Aquilina A, Pineda L, Dhanvantri V, Grant B, Bouquin P. Noninvasive ventilation for prevention of post-extubation respiratory failure in obese patients. Eur Respir J 2006;28(3):588-595.
115. Huerta S, DeShields S, Shpiner R, Li Z, Liu C, Sawicki M, et al. Safety and efficacy of postoperative continuous positive airway pressure to prevent pulmonary complications after Roux-en-Y gastric bypass. J Gastrointest Surg 2002;6(3):354-358.
116. Hensley MJ, Read DJ. Intemittent obstruction of the upper airway during sleep causing profound hypoxaemia. A neglected mechanism exacerbating chronic respiratory failure. Aust N Z J Med 1976;6(5):481-486.
117. Kim SH, Eisele DW, Smith PL, Schneider H, Schwartz AR. Evaluation of patients with sleep apnea after tracheotomy. Arch Otolaryngol Head Neck Surg 1998;124(9):996-1000.
118. Mokhlesi B, Tulaimat A. Recent advances in obesity hypoventilation syndrome. Chest 2007;132(4):1322-1336.
119. Bayliss DA, Millhorn DE. Central neural mechanisms of progesterone action: application to the respiratory system. J Appl Physiol 1992;73(2):393-404.
120. Sutton FD Jr, Zwillich CW, Creagh CE, Pierson DJ, Weil JV. Progesterone for outpatient treatment of Pickwickian syndrome. Ann Intern Med 1975;83(4):476-479.
121. Poulter NR, Chang CL, Farley TM, Meirik O. Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications. Lancet 1999;354(9190):1610.
122. Douketis JD, Julian JA, Kearon C, Anderson DR, Crowther MA, Bates SM, et al. Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective casecontrol study. J Thromb Haemost 2005;3(5):943-948.
123. Skatrud JB, Dempsey JA, Bhansali P, Irvin C. Determinants of chronic carbon dioxide retention and its correction in humans. J Clin Invest 1980;65(4):813-821.
124. Tojima H, Kunitomo F, Kimura H, Tatsumi K, Kuriyama T, Honda Y. Effects of acetazolamide in patients with the sleep apnoea syndrome. Thorax 1988;43(2):113-119.
125. Whyte KF, Gould GA, Airlie MA, Shapiro CM, Douglas NJ. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep 1988;11(5):463-472.